Zhi-Xiong Lin Selected Research

Neoplasms (Cancer)

1/2021	Development and Validation of Prognostic Nomograms Based on Gross Tumor Volume and Cervical Nodal Volume for Nasopharyngeal Carcinoma Patients With Concurrent Chemoradiotherapy.
1/2019	Bioactivity and safety of chimeric switch receptor T cells in glioblastoma patients.
1/2017	Improving the prediction of overall survival for head and neck cancer patients using image biomarkers in combination with clinical parameters.
4/2016	The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study.
3/2016	The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
1/2016	High IFIT1 expression predicts improved clinical outcome, and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma.
1/2015	High Jagged1 expression is associated with poor outcome in primary glioblastoma.
8/2014	High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma.
4/2014	STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma.
1/2014	Association of pSTAT3-VEGF signaling pathway with peritumoral edema in newly diagnosed glioblastoma: an immunohistochemical study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhi-Xiong Lin Research Topics

Disease

16	Neoplasms (Cancer) 01/2021 - 11/2004
11	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2014
8	Glioma (Gliomas) 01/2018 - 07/2010
5	Nasopharyngeal Carcinoma 01/2021 - 09/2016
4	Edema (Dropsy) 11/2015 - 12/2011
3	Brain Edema (Cerebral Edema) 12/2015 - 01/2014
2	Esophageal Squamous Cell Carcinoma 01/2019 - 03/2013
2	Neoplasm Metastasis (Metastasis) 01/2019 - 04/2011
2	Lung Neoplasms (Lung Cancer) 11/2016 - 03/2016
2	Necrosis 11/2015 - 03/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Arthrogryposis renal dysfunction cholestasis syndrome 11/2016
1	AIDS-Related Complex (ARC) 11/2016
1	Breast Neoplasms (Breast Cancer) 03/2016
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2016
1	Carcinogenesis 01/2014
1	Esophageal Neoplasms (Esophageal Cancer) 03/2013
1	Coinfection 01/2012
1	Astrocytoma (Pilocytic Astrocytoma) 07/2010
1	Carcinoma (Carcinomatosis) 11/2009

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 04/2016 - 08/2014
3	delta proteinIBA 04/2016 - 08/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 12/2011
2	Biological ProductsIBA 01/2019 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 12/2011
2	Indicators and Reagents (Reagents)IBA 03/2015 - 04/2014
2	thiamine triphosphorate (TTP)IBA 01/2015 - 08/2014
1	NestinIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Long Noncoding RNAIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Notch1 ReceptorIBA 03/2016
1	MethyltransferasesIBA 01/2016
1	InterferonsIBA 01/2016
1	Periodic AcidIBA 01/2015
1	Temozolomide (Temodar)FDA LinkGeneric 02/2014
1	Tyrosine (L-Tyrosine)FDA Link 01/2014
1	Serine (L-Serine)FDA Link 01/2014
1	Transcription Factor 3IBA 01/2014
1	BariumIBA 03/2013
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	EndostatinsIBA 12/2011
1	Fibronectins (Fibronectin)IBA 07/2010

Therapy/Procedure

10	Radiotherapy 01/2019 - 11/2004
6	Chemoradiotherapy 01/2021 - 04/2014
6	Therapeutics 01/2021 - 04/2011
4	Drug Therapy (Chemotherapy) 01/2018 - 01/2014
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 09/2016 - 11/2009
2	Conformal Radiotherapy 03/2013 - 11/2009
1	Induction Chemotherapy 01/2019
1	Neoadjuvant Therapy 01/2017
1	Subcutaneous Injections 12/2011